In late 2022, Congress passed legislation allowing any DEA-licensed prescriber to prescribe buprenorphine for the treatment of opioid use disorder. Yet, only around half of U.S. pharmacies stock it because of controlled substance purchasing and dispensing requirements. To help bring the lifesaving drug to more communities, NCPA, the National Association of Boards of Pharmacy, the University of Houston College of Pharmacy, and others partnered to create the Pharmacy Access to Resources and Medication for Opioid Use Disorder Practice Guideline, a first-of-its-kind practice guideline for community pharmacists addressing those barriers to access.
In this session, University of Houston College of Pharmacy Assistant Professor Tyler Varisco, PharmD, PhD, will review the evidence around safe and effective use of buprenorphine and how to implement the PhARM-OUD Guideline’s recommendations in practice. Register here. This webinar is sponsored by the Foundation for Opioid Response Efforts.
